![Randall K. Johnson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karriereverlauf von Randall K. Johnson
Ehemalige bekannte Positionen von Randall K. Johnson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Callisto Pharmaceuticals, Inc.
![]() Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | 10.02.2005 | 22.01.2013 |
Independent Dir/Board Member | 10.02.2005 | 22.01.2013 | |
GSK PLC | Corporate Officer/Principal | 01.02.2002 | 01.02.2002 |
Smithkline Beecham Pharmaceuticals (Canada) | Corporate Officer/Principal | - | - |
Statistik
International
Vereinigte Staaten | 2 |
Vereinigtes Königreich | 2 |
Kanada | 2 |
Operativ
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GSK PLC | Health Technology |
Private Unternehmen | 2 |
---|---|
Callisto Pharmaceuticals, Inc.
![]() Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
Smithkline Beecham Pharmaceuticals (Canada) |
- Börse
- Insiders
- Randall K. Johnson
- Erfahrung